Utah Delegates Psychiatric Drug Prescriptions to AI Chatbot in Controversial Pilot

Utah has become the second state in the nation to grant an artificial intelligence system the authority to prescribe psychiatric medications, launching a one-year pilot that bypasses direct physician oversight. The move, announced last week, delegates clinical authority to a chatbot developed by San Francisco startup Legion Health, allowing it to renew certain psychiatric drug prescriptions for a $19 monthly subscription fee. State officials argue the program can reduce costs and alleviate care shortages, but it immediately faces fierce criticism from medical professionals who label the opaque AI system as a significant and risky experiment in patient care.

The pilot centers on Legion Health's AI, which promises Utah-based patients "fast, simple refills." This marks a rare and substantial delegation of prescription authority to a non-human agent, raising fundamental questions about accountability, patient safety, and the standard of care in mental health treatment. Physicians warn that an algorithmic system lacks the nuanced judgment required for psychiatric care and is unlikely to effectively expand access to those most in need, potentially prioritizing convenience over comprehensive treatment.

The program signals a growing pressure to deploy AI for clinical decision-making amid systemic healthcare strains, but it also invites intense scrutiny over regulatory oversight and ethical boundaries. If the pilot proceeds, it could set a precedent for other states grappling with similar shortages, potentially reshaping the landscape of telepsychiatry and prescription management. The core tension lies between the promise of scalable, low-cost solutions and the profound risks of automating deeply personal and complex medical interventions.